Marksans Pharma Limited
MARKSANS

Marksans Pharma Limited

Healthcare
Share price
₹291
Market cap
₹13,183 Cr
1Y return
▲ 51%

A pharmaceutical formulation company engaged in the development and manufacture of a diverse range of drugs across multiple therapeutic areas for domestic and international markets. Marksans Pharma produces generic medications and branded formulations with a focus on quality and regulatory compliance. The company operates modern manufacturing facilities designed to meet stringent pharmaceutical production standards and global quality requirements.

Investors holding Marksans Pharma Limited

UTI Mutual Fund
UTI Mutual Fund
Mutual Fund
1.66%

Recent moves 4

Kotak Mutual FundExited
Kotak Mutual Fund's name has dropped from Marksans Pharma Limited's latest shareholder list. After previously holding a 1.14 percent stake, Kotak Mutual Fund has either fully exited the company or trimmed its position below the 1 percent disclosure threshold.
15 Oct 2026
Read more
UTI Mutual FundDecreased
UTI Mutual Fund trimmed its stake in Marksans Pharma Limited from 2.11% to 1.66%, selling 20,26,054 shares.
15 Oct 2026
Read more
Kotak Mutual FundIncreased
Kotak Mutual Fund increased its stake in Marksans Pharma from 1.13% to 1.14%, buying 20,101 shares.
20 Jul 2026
Read more
UTI Mutual FundDecreased
UTI Mutual Fund decreased its stake in Marksans Pharma from 2.49% to 2.11%, selling 17,45,067 shares.
20 Jul 2026
Read more

Track the whales in Marksans Pharma Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1